provider portal
Validations
RIP SUM (Respiratory Inductive Plethysmography SUM) is a non-invasive method for monitoring respiratory effort and airflow, widely used in sleep apnea diagnosis. This technique combines signals from thoracic and abdominal sensors to measure respiratory effort and airflow without requiring facial sensors. Validated by studies and included in AASM guidelines, RIP SUM provides reliable data on airflow mechanics, distinguishing between obstructive and central apneas. Devices like Wesper LAB leverage this principle to deliver real-time, accurate respiratory monitoring, offering advantages over PAT and PPG technologies by focusing on direct physiological signals, unaffected by peripheral factors or heart arrhythmias, and ensuring high diagnostic accuracy in clinical and home settings.
Continue reading
This article explores the significant impact of Obstructive Sleep Apnea (OSA) on men's health, highlighting the increased risks of cardiovascular complications, hormonal imbalances, and mental health issues. It delves into how OSA, characterized by repeated airway collapses during sleep, leads to poor sleep quality and a host of serious health problems, including heart disease, type 2 diabetes, and depression. The article also discusses the importance of early diagnosis and tailored treatment options, such as CPAP therapy and lifestyle changes, to mitigate these risks and improve overall health outcomes for men.
Continue reading
Central sleep apnea (CSA) is a sleep disorder characterized by intermittent pauses in breathing due to a failure of the brain's respiratory control centers. Unlike obstructive sleep apnea (OSA), where the pauses are caused by physical blockages in the airway,...
Continue reading
Wesper, a leading sleep testing and management service provider, announced today that it received a third clearance from the U.S. Food and Drug Administration (FDA) for its next-generation device.
Continue reading
